ÍMÍtalo Costa Monteiro

Ítalo Costa Monteiro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ítalo Costa Monteiro has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bomba de efluxo MexAB-OprM como fator de resistência antimicrobiana em Pseudomonas aeruginosa: revisão integrativa

    by Natasha Maria Lima Pinheiro, Antonia Gabriella de Souza Freitas, Diogo Thomas Ferreira de Lima, Ítalo Costa Monteiro, Mateus Oliveira Fernandes, Cauan Farias Ananias, Izabell Maria Martins Teixeira, Bruna Ribeiro Duque, Mac Dionys Rodrigues da Costa, Tiago Lima Sampaio

    Background and Objectives: Pseudomonas aeruginosa is an opportunistic pathogen and a major cause of healthcare-associated infections. The World Health Organization (WHO) has identified this pathogen as a critical priority in the context of antimicrobial resistance. Among its resistance mechanisms, the MexAB-OprM efflux pump plays an important role in reducing susceptibility to antimicrobial agents. This integrative review aimed to examine the relationship between the MexAB-OprM efflux pump and antimicrobial resistance in P. aeruginosa, with the broader goal of contributing to the development of effective clinical management strategies. Content: A literature search identified 113 records. Studies were screened based on predefined eligibility criteria. Reviews, meta-analyses, articles for which the full text was unavailable, and studies that did not focus on P. aeruginosa and the MexAB-OprM efflux pump were excluded during the initial screening. In the subsequent stage, studies that did not specifically address the role of this efflux system in antimicrobial resistance were also excluded. Following the selection process, 24 studies were included in the review. The findings indicate that the MexAB-OprM efflux pump contributes to antimicrobial resistance in P. aeruginosa. Moreover, its contribution is not independent of other resistance mechanisms but frequently occurs in conjunction with them, particularly β-lactamase production. Conclusion: MexAB-OprM-mediated resistance poses a significant challenge to the clinical management of infections caused by multidrug-resistant P. aeruginosa, particularly in healthcare settings. Further research into the role of this efflux system, alongside a critical assessment of current treatment protocols, is warranted to improve therapeutic strategies and mitigate the impact of antimicrobial resistance.

  • Open Access

    Susceptibility profile of Staphylococcus aureus isolates in blood cultures from a tertiary hospital - comparison of methods for determination of minimum inhibitory concentration of vancomycin

    by Rejane Moraes Falcão, Ana Júlia Batista Pereira, Natasha Maria Lima Pinheiro, Pedro Nonato da Junior Silva, Ítalo Costa Monteiro, Francisco Janeto Lopes Filho Dantas, Bruna Ribeiro Duque, Izabell Maria Martins Teixeira, Mac Dionys Rodrigues Da Costa, Emanuel Paula Magalhães, et al.

    Objective: to evaluate the antimicrobial susceptibility profile of Staphylococcus aureus isolates from blood cultures and compare methods for determiningthe minimum inhibitory concentration (MIC) of vancomycin. Methods: an observational study conducted in a tertiary hospital, involving 62 clinical isolates of S. aureus. In addition, the MIC of vancomycin was determined using the Etest®, broth microdilution (BMD), and Vitek® automated system methods. Clinically relevant antimicrobial susceptibility profiles were evaluated, and agreement between methods was analyzed by statistical correlationusing IBM-SPSS® software. The study was approved by the hospital's Research Ethics Committee under registration number 5.557.687/2022. Results: methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) isolates were susceptible to vancomycin, teicoplanin, linezolid, daptomycin, and tigecycline. A better correlation was observed between the vancomycin MIC values obtained by Vitek®2 and BMD compared to Etest®. However, Vitek®2 tended to overestimate MIC compared to BMD. Conclusion: the results indicate the importance of using complementary methods to validate high vancomycin MIC values, contributing to more appropriate therapeutic decisions and the prevention of bacterial resistance.

  • Open Access

    SUSCEPTIBILITY PROFILE OF Staphylococcus aureus BLOOD ISOLATES AND COMPARISON OF VANCOMYCIN MIC DETERMINATION METHODS

    by Rejane Moraes Falcão, Ana Júlia Batista Pereira, Natasha Maria Lima Pinheiro, Pedro Nonato da Silva Júnior, Ítalo Monteiro, Francisco Janeto Lopes Dantas Filho, Bruna Ribeiro Duque, Izabell Maria Martins Teixeira, Mac Dionys Rodrigues da Costa, Emanuel Paula Magalhães, et al.

    Introduction: The existence of inconsistencies in the vancomycin minimum inhibitory concentration (MIC) for Staphylococcus aureus obtained by automated methods when compared with the results obtained by methods such as Etest ® and broth microdilution (BMD) shows the necessity of evaluate and compare these results. Materials and Methods: Regarding that, vancomycin MIC, and susceptibility profiles of 62 S. aureus isolates from blood cultures were all determined using the Etest ® , BMD, and Vitek ® 2 methods, these three methods evaluating their susceptibility profiles. Results and Discussion: Methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) S. aureus strains showed susceptibility to vancomycin, teicoplanin, linezolid, daptomycin and tigecycline. Vitek ® 2 (r = 0.6975, p® (r = 0.2563, p® 2 was overestimated by MIC compared to BMD. Conclusion: Therefore, it is recommended to implement complementary methods to confirm if the high vancomycin MIC results are valid, thereby avoiding inappropriate use of antibiotics and the increase of resistance.